business

AstraZeneca’s (AZN) CARES Phase III Clinical Programme Fails to Meet Primary End Point

Yahoo Finance · Jun 2, 2026, 2:14 PM · Also reported by 1 other source

Read full story on Yahoo Finance → More top stories

Also covered by

Investing.com Praxis reports phase 2/3 epilepsy trial missed primary endpoint

Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

AstraZeneca’s (AZN) CARES Phase III Clinical Programme Fails to Meet Primary End Point

Also covered by

More in business